Myriam Curet Sells 105 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 105 shares of the company’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $560.00, for a total transaction of $58,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Myriam Curet also recently made the following trade(s):

• On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The stock was sold at an average price of $548.43, for a total transaction of $4,147,227.66.
• On Wednesday, October 29th, Myriam Curet sold 125 shares of Intuitive Surgical stock. The shares were sold at an average price of $543.00, for a total transaction of $67,875.00.

Intuitive Surgical Trading Up 0.0%

ISRG stock traded up $0.28 during mid-day trading on Wednesday, hitting $572.45. 1,632,272 shares of the company were exchanged, compared to its average volume of 2,121,198. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market capitalization of $205.21 billion, a PE ratio of 75.72, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The business has a 50 day simple moving average of $476.01 and a 200-day simple moving average of $502.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter last year, the company earned $1.84 earnings per share. Equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ISRG. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a report on Wednesday, October 22nd. HSBC upped their target price on Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Argus boosted their price target on Intuitive Surgical from $600.00 to $630.00 in a report on Monday, October 27th. UBS Group set a $600.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a report on Thursday, October 23rd. Finally, Wells Fargo & Company boosted their target price on shares of Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Tobam lifted its stake in Intuitive Surgical by 666.7% in the second quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares during the period. Kilter Group LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth $27,000. Greykasell Wealth Strategies Inc. bought a new stake in Intuitive Surgical during the 3rd quarter valued at $27,000. TD Capital Management LLC raised its holdings in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 45 shares during the last quarter. Finally, 1248 Management LLC acquired a new position in shares of Intuitive Surgical during the first quarter valued at about $30,000. 83.64% of the stock is owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.